UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between bladder cancer and kidney cancer clinical trials and research opportunities
~10,200 new UK cases annually. BCG-unresponsive disease and muscle-invasive bladder cancer are major trial focus areas with immunotherapy advances.
~13,300 new UK cases annually. Clear cell RCC dominates trial activity with VEGF/TKI and immunotherapy combinations in evolving treatment landscapes.
Bladder cancer trials span BCG alternatives to radical surgery options. Kidney cancer trials are dominated by systemic therapy sequencing in metastatic disease.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
